Forvia (FRVIA) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
20 Nov, 2025Opening remarks and agenda
Meeting opened with multilingual support, acknowledgment of shareholders, and a comprehensive agenda covering financial results, governance, compensation, and strategic initiatives.
Board members, key executives, and major shareholders were introduced; agenda and legal quorum confirmed.
Financial performance review
2024 sales reached EUR 27 billion, with 0.4% organic growth and a resilient 5.2% operating margin, outperforming a declining market.
Net cash flow was EUR 655 million, above target; net debt reduced by almost EUR 400 million, leverage ratio improved to just under 2x.
Net income was EUR 185 million, impacted by restructuring costs and non-recurring expenses; 2024 net loss mainly due to increased restructuring costs.
Q1 2025 sales showed 2.1% organic growth, with strong performance in seating and electronics.
2025 guidance: sales EUR 26.3–27.5 billion, operating margin 5.2–6%, net debt/EBITDA <1.8x, further deleveraging targeted.
Board and executive committee updates
Martin Fischer appointed CEO in March 2025, succeeding Patrick Koller, who was recognized for his decade of leadership.
Board changes included the departure of Nikolas Peter and the proposed appointment of Lutz Meschke effective January 2026.
Board composition: 14 directors, 42% women, 83% independent, 5 nationalities; committee chairs presented reports.
Board and committees held 34 meetings in 2024, with 100% attendance.
Latest events from Forvia
- 2024 outlook cut; accelerated cost and China growth actions target stronger 2025 results.FRVIA
Guidance10 Mar 2026 - Margin gains, strong cash flow, and portfolio reshaping set the stage for future growth.FRVIA
Q4 2025 & CMD24 Feb 2026 - Operating margin and cash flow rose, guidance confirmed despite SYMBIO-related net loss.FRVIA
Q2 20253 Feb 2026 - 2.7% organic sales growth, margin gains, and deleveraging progress marked H1 2024.FRVIA
Q2 20243 Feb 2026 - Q3 sales outperformed the market by 420bps, with strong order intake and margin focus.FRVIA
Q3 202419 Jan 2026 - Q1 2025 sales up 2.6% to €6.7bn, 2025 guidance confirmed amid market volatility.FRVIA
Q1 202525 Dec 2025 - Resilient 2024 results, strong cash flow, and further deleveraging targeted for 2025.FRVIA
Q4 202418 Dec 2025 - Stable Q3 sales and strong cost discipline support confirmed 2025 guidance amid mixed segment trends.FRVIA
Q3 202520 Oct 2025